Pancreatic Adenosquamous Carcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenosquamous Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation [Phase 2]
ClinicalTrials.gov update describes a Phase II randomized study (APOLLO) comparing olaparib versus placebo after curative-intent therapy in …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 3]
A Phase 3 clinical trial evaluating Daraxonrasib alone and in combination with gemcitabine and nab-paclitaxel as first-line therapy for meta…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer [Phase 3]
A Phase 3 clinical trial update evaluating the use of standard chemotherapy before and after surgery for resectable pancreatic cancer is cur…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update for the PLATINUM study evaluating second-line platinum-based chemotherapy for metastatic BRCA1/2- or PALB2-associated …
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 clinical trial is evaluating Th-1 dendritic cell immunotherapy in combination with standard chemotherapy for pancreatic adenocarci…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.